Our founders’ insights and achievements

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure

NuMat Medtech secures a €530,000 round of investment

Minoryx Therapeutics raises €21.3M in Series B funding round

QIAGEN enters into agreement to acquire STAT-Dx, a Caixa Capital Risc portfolio company

MedLumics, a company owned by “la Caixa” and Ysios Capital, closes a financing round of 34.4 million euros

Minoryx Therapeutics Initiates Phase 1 clinical trial of MIN-102

Stat Diagnostica announces 25 Million Euros in Series C Financing

”la Caixa” leads an investment round in Inbiomotion with the participation of Ysios Capital

Minoryx Therapeutics appoints Dr. Khalid Islam as chairman of the board of directors